EUVIMEDEUVIMED entdecken
Crossref

Why highly proliferative pancreatic neuroendocrine‐like tumours require dual lineage assessment

Sunder Sham iD, Qingqing Liu iD

Histopathology · 2026-06 · 88 (7) · 1464-1465

DOI: 10.1111/his.70134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, online erschienen am 09.03.2026. Verfasst von Sunder Sham und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Die Arbeit nennt 6 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

ORCID-Profile: Sunder Sham, Qingqing Liu

Zitieren

APA

Sham, S., & Liu, Q. (2026). Why highly proliferative pancreatic neuroendocrine‐like tumours require dual lineage assessment. Histopathology, 88(7), 1464-1465. https://doi.org/10.1111/his.70134

Vancouver

Sham S, Liu Q. Why highly proliferative pancreatic neuroendocrine‐like tumours require dual lineage assessment. Histopathology. 2026;88(7):1464-1465. doi:10.1111/his.70134

BibTeX
@article{Sham2026,
  author = {Sham, Sunder and Liu, Qingqing},
  title = {Why highly proliferative pancreatic neuroendocrine‐like tumours require dual lineage assessment},
  journal = {Histopathology},
  year = {2026},
  volume = {88},
  number = {7},
  pages = {1464--1465},
  doi = {10.1111/his.70134}
}
Kostenlos starten →